Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report

Author： Kapur Rick   Stramrood Claire   Schutgens Roger   van Asbeck B. Sweder  

Publisher： Informa Healthcare

ISSN： 1473-0782

Source： The European Journal of Contraception and Reproductive Health Care, Vol.14, Iss.2, 2009-04, pp. : 160-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate

By Vartiainen M.   de Gezelle H.   Broekmeulen C. J. H.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 1, 2001-03 ,pp. : 46-53

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of combined ethinyloestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome

By Falsetti L.   Ramazzotto Francesca   Rosina Barbara  

Journal of Obstetrics & Gynaecology, Vol. 17, Iss. 6, 1997-12 ,pp. : 565-568

Informa Healthcare

Access to resources Recommend Favorite

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

By Bitzer Johannes   Amy Jean-Jacques  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 3, 2013-06 ,pp. : 143-147

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen

By Mansour Diana   Verhoeven Carole   Sommer Werner   Weisberg Edith   Taneepanichskul Surasak   Melis Gian Benedetto   Sundström-Poromaa Inger   Korver Tjeerd  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 6, 2011-12 ,pp. : 430-443

Informa Healthcare

Access to resources Recommend Favorite

Twenty or thirty microgram ethinyloestradiol in an oral contraceptive: Does it make a difference in the mind and the daily practise of gynaecologists and general practitioners?

By Bitzer J.   Frey B.   von Schonau M.   Sabler N.   Tschudin S.  

The European Journal of Contraception and Reproductive Health Care, Vol. 14, Iss. 4, 2009-08 ,pp. : 258-267

Informa Healthcare

Access to resources Recommend Favorite